Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current HIV/AIDS Reports|May 31, 2008
Pathogenesis and management of lipoatrophyMarisa Tungsiripat, Grace McComseyCleveland Clinic Journal of Medicine|January 6, 2006
Dyslipidemia in HIV patientsMarisa Tungsiripat, Judith A AbergJournal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 20, 2008
Prevalence and significance of G6PD deficiency in patients of an urban HIV clinicMarisa Tungsiripat, Henning Drechsler, Christine Sarlone, et al.Open Forum Infectious Diseases|December 5, 2025
Prevalence of Neisseria meningitidis by Molecular Testing in Urine Specimens From Men in OhioHannah Wang, Bethany Burns, Deborah Wilson, et al.Arthritis Care & Research|June 23, 2016
Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune DiseasesSintawat Wangsiricharoen, Colin Ligon, Lydia Gedmintas, et al.Diagnostic Microbiology and Infectious Disease|June 26, 2017
Preanalytic process linked to spuriously elevated HIV viral loads: improvement on an FDA-approved processGary W Procop, Alan J Taege, Colleen Starkey, et al.HIV Clinical Trials|November 13, 2009
Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fatMarisa Tungsiripat, Mary Ann O'Riordan, Norma Storer, et al.HIV Clinical Trials|June 13, 2008
Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adultsDalia El-Bejjani, Stanley L Hazen, Wilma Mackay, et al.AIDS (London, England)|May 11, 2010
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimensMarisa Tungsiripat, Dalia El Bejjani, Nesrine Rizk, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 14, 2014
HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countriesMohammed K Ali, Matthew J Magee, Joel A Dave, et al.Pageof 2